Yong Sok Kwon

Array ( [id] => 6674884 [patent_doc_number] => 20030060487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Treatment of neurodegenerative disease' [patent_app_type] => new [patent_app_number] => 09/835099 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20740 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060487.pdf [firstpage_image] =>[orig_patent_app_number] => 09835099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 505821 [patent_doc_number] => 07202276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia' [patent_app_type] => utility [patent_app_number] => 09/833257 [patent_app_country] => US [patent_app_date] => 2001-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 12656 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202276.pdf [firstpage_image] =>[orig_patent_app_number] => 09833257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575423 [patent_doc_number] => 06469062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-10-22 [patent_title] => 'Use of 15-keto-prostaglandins in promoting bile secretion' [patent_app_type] => B2 [patent_app_number] => 09/827375 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6708 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469062.pdf [firstpage_image] =>[orig_patent_app_number] => 09827375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291895 [patent_doc_number] => 20020055530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Compositions and methods for promoting tissue regeneration' [patent_app_type] => new [patent_app_number] => 09/827666 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16313 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055530.pdf [firstpage_image] =>[orig_patent_app_number] => 09827666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1374095 [patent_doc_number] => 06562837 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Use of tetrahydroisoquinoline compounds for the treatment of septicemia' [patent_app_type] => B1 [patent_app_number] => 09/806389 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 8635 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562837.pdf [firstpage_image] =>[orig_patent_app_number] => 09806389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1378232 [patent_doc_number] => 06559154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-06 [patent_title] => 'Composition of sodium channel blocking compound' [patent_app_type] => B2 [patent_app_number] => 09/819796 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 7821 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559154.pdf [firstpage_image] =>[orig_patent_app_number] => 09819796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014690 [patent_doc_number] => 06894032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Use of CDP-choline for the treatment of alcohol withdrawal syndrome' [patent_app_type] => utility [patent_app_number] => 10/240159 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1068 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894032.pdf [firstpage_image] =>[orig_patent_app_number] => 10240159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6987388 [patent_doc_number] => 20010036959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Carvedilol-hydrophilic solutions' [patent_app_type] => new [patent_app_number] => 09/817308 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4465 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036959.pdf [firstpage_image] =>[orig_patent_app_number] => 09817308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669508 [patent_doc_number] => 20030114492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Method of using neurotrophic sulfonamide compounds' [patent_app_type] => new [patent_app_number] => 09/814954 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7616 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 369 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114492.pdf [firstpage_image] =>[orig_patent_app_number] => 09814954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439351 [patent_doc_number] => 20020128235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Prevention and/or treatment of diabetes mellitus by pharmacologically inhibiting pancreatic beta-cell O-linked protein glycosylation and/or pancreatic beta-cell p135 O-glycosylation' [patent_app_type] => new [patent_app_number] => 09/813534 [patent_app_country] => US [patent_app_date] => 2001-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4005 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128235.pdf [firstpage_image] =>[orig_patent_app_number] => 09813534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7450554 [patent_doc_number] => 20040010044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Medicaments' [patent_app_type] => new [patent_app_number] => 10/239342 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 1779 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010044.pdf [firstpage_image] =>[orig_patent_app_number] => 10239342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6451641 [patent_doc_number] => 20020177624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Acetate-lactate buffering vaginal gel and for method of making same and treating bacterial vaginosis' [patent_app_type] => new [patent_app_number] => 09/809835 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4860 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177624.pdf [firstpage_image] =>[orig_patent_app_number] => 09809835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595304 [patent_doc_number] => 06384051 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Method of treating or inhibiting colonic polyps' [patent_app_type] => B1 [patent_app_number] => 09/805070 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54359 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 664 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384051.pdf [firstpage_image] =>[orig_patent_app_number] => 09805070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517546 [patent_doc_number] => 06500816 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Remedies for photochemotherapy' [patent_app_type] => B1 [patent_app_number] => 09/786874 [patent_app_country] => US [patent_app_date] => 2001-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8234 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500816.pdf [firstpage_image] =>[orig_patent_app_number] => 09786874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1111447 [patent_doc_number] => 06806293 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-19 [patent_title] => 'Use of pheromone compounds having MAP kinase modulating activity' [patent_app_type] => B1 [patent_app_number] => 09/804209 [patent_app_country] => US [patent_app_date] => 2001-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6923 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806293.pdf [firstpage_image] =>[orig_patent_app_number] => 09804209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880600 [patent_doc_number] => 20010031887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Optically active phosphate derivative and its use' [patent_app_type] => new [patent_app_number] => 09/801041 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3256 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031887.pdf [firstpage_image] =>[orig_patent_app_number] => 09801041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7634649 [patent_doc_number] => 06656970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-02 [patent_title] => 'Method and compositions for solubilization of pentacyclic triterpenes' [patent_app_type] => B2 [patent_app_number] => 09/802293 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3757 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656970.pdf [firstpage_image] =>[orig_patent_app_number] => 09802293 [rel_patent_id] =>[rel_patent_doc_number] =>)